Back to Search Start Over

LBA27A randomized multicentered phase II study to evaluate SHR-1210 (PD-1 antibody) in subjects with advanced hepatocellular carcinoma (HCC) who failed or intolerable to prior systemic treatment.

Authors :
Qin, S K
Ren, Z G
Meng, Z Q
Chen, Z D
Chai, X L
Xiong, J P
Bai, Y X
Yang, L
Zhu, H
Fang, W J
Source :
Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. 1 Chart.
Publication Year :
2018

Details

Language :
English
ISSN :
09237534
Volume :
29
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
133285998
Full Text :
https://doi.org/10.1093/annonc/mdy424.029